Thrivent Financial For Lutherans Johnson & Johnson Transaction History

Thrivent Financial For Lutherans

  • $50.8 Billion
  • Q3 2025

A detailed history of Thrivent Financial For Lutherans transactions in Johnson & Johnson stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 1,773,874 shares of JNJ stock, worth $354 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
1,773,874
Previous 1,510,207 17.46%
Holding current value
$354 Million
Previous $231 Million 42.59%
% of portfolio
0.65%
Previous 0.5%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025
BUY
$155.17 - $185.42 $40.9 Million - $48.9 Million
263,667 Added 17.46%
1,773,874 $329 Million
Q2 2025

Aug 26, 2025
BUY
$146.36 - $159.82 $5.89 Million - $6.43 Million
40,239 Added 2.74%
1,510,207 $231 Million
Q2 2025

Aug 11, 2025
SELL
$146.36 - $159.82 $132 Million - $144 Million
-902,964 Reduced 87.52%
128,800 $19.7 Million
Q1 2025

Aug 26, 2025
BUY
$142.06 - $167.7 $191 Million - $225 Million
1,341,168 Added 1041.28%
1,469,968 $243 Million
Q1 2025

May 13, 2025
SELL
$142.06 - $167.7 $66.6 Million - $78.6 Million
-468,553 Reduced 31.23%
1,031,764 $171 Million
Q4 2024

Feb 10, 2025
SELL
$143.34 - $165.86 $7.94 Million - $9.19 Million
-55,395 Reduced 3.56%
1,500,317 $217 Million
Q3 2024

Nov 07, 2024
SELL
$145.48 - $167.38 $11.5 Million - $13.2 Million
-79,151 Reduced 4.84%
1,555,712 $252 Million
Q2 2024

Aug 13, 2024
BUY
$144.38 - $157.78 $57 Million - $62.2 Million
394,518 Added 31.81%
1,634,863 $239 Million
Q1 2024

May 14, 2024
BUY
$155.22 - $162.74 $51.4 Million - $53.9 Million
331,299 Added 36.44%
1,240,345 $196 Million
Q4 2023

Feb 14, 2024
SELL
$145.6 - $158.88 $4.57 Million - $4.98 Million
-31,373 Reduced 3.34%
909,046 $142 Million
Q3 2023

Nov 14, 2023
SELL
$155.75 - $174.48 $52.9 Million - $59.2 Million
-339,529 Reduced 26.53%
940,419 $146 Million
Q2 2023

Aug 14, 2023
BUY
$154.35 - $166.11 $16.2 Million - $17.5 Million
105,214 Added 8.96%
1,279,948 $212 Million
Q1 2023

May 17, 2023
SELL
$151.05 - $180.26 $5.71 Million - $6.81 Million
-37,806 Reduced 3.12%
1,174,734 $182 Million
Q4 2022

Feb 08, 2023
SELL
$160.2 - $179.79 $36.5 Million - $40.9 Million
-227,622 Reduced 15.81%
1,212,540 $214 Million
Q3 2022

Nov 14, 2022
BUY
$161.33 - $179.52 $11.5 Million - $12.8 Million
71,541 Added 5.23%
1,440,162 $235 Million
Q2 2022

Aug 16, 2022
SELL
$168.19 - $186.01 $14.7 Million - $16.2 Million
-87,249 Reduced 5.99%
1,368,621 $243 Million
Q1 2022

May 13, 2022
BUY
$158.14 - $179.59 $6.29 Million - $7.14 Million
39,780 Added 2.81%
1,455,870 $258 Million
Q4 2021

Feb 16, 2022
BUY
$155.93 - $173.01 $6.71 Million - $7.45 Million
43,053 Added 3.14%
1,416,090 $242 Million
Q3 2021

Nov 15, 2021
BUY
$161.5 - $179.47 $4.59 Million - $5.1 Million
28,404 Added 2.11%
1,373,037 $222 Million
Q2 2021

Sep 24, 2021
BUY
$159.48 - $171.07 $8.33 Million - $8.94 Million
52,248 Added 4.04%
1,344,633 $222 Million
Q2 2021

Aug 19, 2021
SELL
$159.48 - $171.07 $4.23 Million - $4.54 Million
-26,554 Reduced 2.01%
1,292,385 $213 Million
Q1 2021

May 17, 2021
SELL
$153.07 - $170.48 $19.5 Million - $21.7 Million
-127,403 Reduced 8.81%
1,318,939 $217 Million
Q4 2020

Feb 16, 2021
SELL
$137.11 - $157.38 $8.96 Million - $10.3 Million
-65,327 Reduced 4.32%
1,446,342 $228 Million
Q3 2020

Nov 10, 2020
SELL
$140.38 - $153.83 $1.18 Million - $1.29 Million
-8,374 Reduced 0.55%
1,511,669 $225 Million
Q2 2020

Aug 12, 2020
SELL
$128.81 - $155.51 $1.35 Million - $1.63 Million
-10,498 Reduced 0.69%
1,520,043 $213 Million
Q1 2020

May 15, 2020
SELL
$111.14 - $153.99 $2.19 Million - $3.03 Million
-19,691 Reduced 1.27%
1,530,541 $201 Million
Q4 2019

Feb 13, 2020
BUY
$127.5 - $146.44 $509,362 - $585,027
3,995 Added 0.26%
1,550,232 $226 Million
Q3 2019

Nov 14, 2019
SELL
$126.95 - $142.14 $5.8 Million - $6.5 Million
-45,707 Reduced 2.87%
1,546,237 $200 Million
Q2 2019

Aug 13, 2019
BUY
$131.15 - $144.24 $3.75 Million - $4.12 Million
28,592 Added 1.83%
1,591,944 $222 Million
Q1 2019

May 14, 2019
BUY
$125.72 - $139.79 $1.22 Million - $1.36 Million
9,727 Added 0.63%
1,563,352 $219 Million
Q4 2018

Feb 15, 2019
BUY
$122.84 - $147.84 $45.6 Million - $54.9 Million
371,404 Added 31.42%
1,553,625 $201 Million
Q3 2018

Nov 15, 2018
SELL
$121.58 - $142.88 $6.22 Million - $7.31 Million
-51,174 Reduced 4.15%
1,182,221 $163 Million
Q2 2018

Aug 14, 2018
BUY
$119.4 - $131.76 $1.25 Million - $1.38 Million
10,441 Added 0.85%
1,233,395 $150 Million
Q1 2018

May 08, 2018
BUY
$125.1 - $148.14 $85 Million - $101 Million
679,618 Added 125.08%
1,222,954 $157 Million
Q4 2017

Feb 14, 2018
BUY
$131.22 - $143.62 $1.99 Million - $2.18 Million
15,161 Added 2.87%
543,336 $75.9 Million
Q3 2017

Nov 14, 2017
BUY
$129.47 - $135.38 $68.4 Million - $71.5 Million
528,175
528,175 $68.7 Million

Others Institutions Holding JNJ

# of Institutions
4,865
Shares Held
1.74B
Call Options Held
19.8M
Put Options Held
16.8M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email